• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

CCE Prostate Cancer: Johns Hopkins -- Selection criteria


Awards and distinctions that make Johns Hopkins' Brady Urological Institute a Center of Excellence.


Hopkins University

, Maryland

Johns Hopkins’ James Buchanan Brady Urological Institute in fiscal 2008 received $9 million in grants from the National Cancer Institute.

Patrick Walsh, MD, University Distinguished Service Professor of Urology at the Johns Hopkins Medical Institutions, pioneered the development of the anatomic approach to radical prostatectomy, using nerve-sparing techniques that have reduced the probability of impotence and incontinence in prostate cancer patients.

Walsh in 2004 received the American Urological Association’s highest honor, the Ramon Guiteras award.

One facet of work that connects Alan Partin, MD, to Walsh, and has made him well-known in urology academia, is the eponymous set of tables that has given thousands of men with prostate cancer worldwide a 95 percent accurate prediction of their likelihood of being cured by treatment. The Partin Tables were developed at the Brady Institute in 1993 after Partin studied the course of prostate cancer in hundreds of Walsh’s radical prostatectomy patients. The tables correlate three key pieces of the prostate cancer puzzle: a man’s PSA score, Gleason score, and estimated stage of cancer.

Related Videos